Shareholders' equity · 2011–2025
Haemonetics shareholders' equity
$911M+0.5% · FY2025
Haemonetics (HAE) reported $911M in shareholders' equity for fiscal 2025, +0.5% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-27 | $911M | +0.5% | Open → |
| FY20242024-12-28 | $907M | −3.9% | Open → |
| FY20232023-12-30 | $943M | +21.6% | Open → |
| FY20222022-12-31 | $776M | +6.2% | Open → |
| FY20212022-01-01 | $731M | +1.6% | Open → |
| FY20202020-12-26 | $719M | +25.2% | Open → |
| FY20192019-12-28 | $575M | −2.8% | Open → |
| FY20182018-12-29 | $591M | −28.2% | Open → |
| FY20172017-12-30 | $823M | +6.7% | Open → |
| FY20162016-12-31 | $771M | +7.1% | Open → |
| FY20152015-12-26 | $720M | −13.7% | Open → |
| FY20142014-12-27 | $834M | +1.1% | Open → |
| FY20132013-12-28 | $825M | +5.9% | Open → |
| FY20122012-12-29 | $779M | +10.5% | Open → |
| FY20112011-12-31 | $705M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +1.8%
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Haemonetics shareholders' equity |url=https://companiesranked.com/en/company/haemonetics/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Haemonetics shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/haemonetics/shareholders-equityBibTeX
@misc{companiesranked-en-company-haemonetics-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Haemonetics shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/haemonetics/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0000313143-26-000010 · February 5, 2026
{{cite web |title=Haemonetics shareholders' equity — 10-Q (0000313143-26-000010) |url=https://www.sec.gov/Archives/edgar/data/313143/000031314326000010/hae-20251227.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.